Big Data company Saama Technologies, which provides analytic platforms to health organizations and other customers, has gotten $35 million in new funding.
An analysis by Avalere suggests that government health programs will spend $50 billion over the next ten years just on ten new specialty drugs,including hepatitis C, cancer and cholesterol lowering medications.
Where to start? In a surge of untouched innocence, investors have provided Virgin Pulse with $92 million, that's right, $92 million, to support its "next-generation" employee well-being platform.
A study published in the Annals of Internal Medicine finds differences in patients readmitted soon after hospital discharge versus those readmitted later in a 30-day window, informing strategies to prevent readmissions.
http://annals.org/article.aspx?articleid=2299852
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.